| __timestamp | Alnylam Pharmaceuticals, Inc. | BioCryst Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 50561000 | 13486000 |
| Thursday, January 1, 2015 | 41097000 | 46361000 |
| Friday, January 1, 2016 | 47159000 | 23654000 |
| Sunday, January 1, 2017 | 76545000 | 23484000 |
| Monday, January 1, 2018 | 73106000 | 20182000 |
| Tuesday, January 1, 2019 | 194688000 | 44734000 |
| Wednesday, January 1, 2020 | 414801000 | 16136000 |
| Friday, January 1, 2021 | 704143000 | 149906000 |
| Saturday, January 1, 2022 | 868601000 | 264233000 |
| Sunday, January 1, 2023 | 1517886000 | 326751000 |
| Monday, January 1, 2024 | 1924873000 |
Unveiling the hidden dimensions of data
In the competitive landscape of biotechnology, Alnylam Pharmaceuticals and BioCryst Pharmaceuticals have shown distinct trajectories in their gross profit trends over the past decade. Starting in 2014, Alnylam's gross profit was modest, but by 2023, it skyrocketed by over 2,900%, reaching a peak. This remarkable growth reflects Alnylam's strategic advancements and successful product launches. In contrast, BioCryst's journey, while positive, was more gradual, with a growth of approximately 2,300% over the same period. This divergence highlights the varying strategies and market responses each company faced. Alnylam's aggressive expansion and innovation have clearly paid off, while BioCryst's steady approach has also yielded significant gains. As the biotech industry continues to evolve, these trends underscore the importance of strategic planning and market adaptation in achieving financial success.
Key Insights on Gross Profit: AbbVie Inc. vs BioCryst Pharmaceuticals, Inc.
Merck & Co., Inc. and BioCryst Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Alnylam Pharmaceuticals, Inc. and Dr. Reddy's Laboratories Limited: A Detailed Gross Profit Analysis
Gross Profit Comparison: Alnylam Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc. Trends
Gross Profit Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Alkermes plc
Gross Profit Comparison: Alnylam Pharmaceuticals, Inc. and Veracyte, Inc. Trends
Gross Profit Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Vericel Corporation
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or Ligand Pharmaceuticals Incorporated
Alnylam Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Gross Profit Trends Compared: Alnylam Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Bio-Techne Corporation and BioCryst Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Perrigo Company plc and BioCryst Pharmaceuticals, Inc.